Project Details
Description
A Phase 1, Open-label Study of ASP9801, an Oncolytic Virus, Administered by Intratumoral Injection in Patients with Advanced/Metastatic Solid Tumors
| Status | Active |
|---|---|
| Effective start/end date | 12/1/20 → 12/31/25 |
Funding
- ASTELLAS PHARMA, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.